IMA Advisory Services’s NovoCure NVCR Stock Holding History

IMA Advisory Services’s Portfolio NVCR Stock Details NVCR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-100	Closed	-$1.61K	–	205
2023 Q3	$1.61K	Hold	100	–	–	﹤0.01%	273
2023 Q2	$4.15K	Hold	100	–	–	﹤0.01%	266
2023 Q1	$6.01K	Hold	100	–	–	﹤0.01%	256
2022 Q4	$7.33K	Hold	100	–	–	﹤0.01%	272
2022 Q3	$8K	Hold	100	–	–	﹤0.01%	261
2022 Q2	$7K	Hold	100	–	–	﹤0.01%	274
2022 Q1	$8K	Hold	100	–	–	﹤0.01%	251
2021 Q4	$8K	Buy	+100	New	+$10K	﹤0.01%	265

Other funds holding NVCR

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return

IMA Advisory Services's NVCR Position: Q4 2023 in Review

IMA Advisory Services sold out of NovoCure (NVCR) in Q4 2023, closing a stake of 100 shares — an estimated $1.61K sold.

IMA Advisory Services first reported a position in NVCR in Q4 2021 and held it in 8 quarters. The position peaked at $8K in Q3 2022. 219 funds tracked by Wall St. Rank hold NVCR as of Q4 2023.

IMA Advisory Services reported no remaining NovoCure position as of Q4 2023 after selling out during the quarter.
IMA Advisory Services sold 100 NovoCure shares in Q4 2023, an estimated $1.61K.
IMA Advisory Services first reported a position in NovoCure in Q4 2021 and held it in 8 quarters.
IMA Advisory Services's NovoCure position peaked at $8K in Q3 2022.
219 funds tracked by Wall St. Rank held NovoCure as of Q4 2023.

Based on IMA Advisory Services's 13F filing for Q4 2023, filed 5 Feb 2024.